Cargando…
Preclinical safety testing of an affinity-optimised MAGE-A10 T cell receptor for adoptive T cell therapy
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646050/ http://dx.doi.org/10.1186/2051-1426-3-S2-P14 |
| _version_ | 1782400911909322752 |
|---|---|
| author | Gerry, Andrew Sanderson, Joseph Saini, Manoj Tavano, Barbara Docta, Roslin Pumphrey, Nicholas Maroto, Miguel Border, Ellen Bennett, Alan Binder-Scholl, Gwendolyn Holdich, Tom Pandite, Lini Amado, Rafael Jakobsen, Bent |
| author_facet | Gerry, Andrew Sanderson, Joseph Saini, Manoj Tavano, Barbara Docta, Roslin Pumphrey, Nicholas Maroto, Miguel Border, Ellen Bennett, Alan Binder-Scholl, Gwendolyn Holdich, Tom Pandite, Lini Amado, Rafael Jakobsen, Bent |
| author_sort | Gerry, Andrew |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4646050 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46460502015-11-20 Preclinical safety testing of an affinity-optimised MAGE-A10 T cell receptor for adoptive T cell therapy Gerry, Andrew Sanderson, Joseph Saini, Manoj Tavano, Barbara Docta, Roslin Pumphrey, Nicholas Maroto, Miguel Border, Ellen Bennett, Alan Binder-Scholl, Gwendolyn Holdich, Tom Pandite, Lini Amado, Rafael Jakobsen, Bent J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4646050/ http://dx.doi.org/10.1186/2051-1426-3-S2-P14 Text en Copyright © 2015 Gerry et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Gerry, Andrew Sanderson, Joseph Saini, Manoj Tavano, Barbara Docta, Roslin Pumphrey, Nicholas Maroto, Miguel Border, Ellen Bennett, Alan Binder-Scholl, Gwendolyn Holdich, Tom Pandite, Lini Amado, Rafael Jakobsen, Bent Preclinical safety testing of an affinity-optimised MAGE-A10 T cell receptor for adoptive T cell therapy |
| title | Preclinical safety testing of an affinity-optimised MAGE-A10 T cell receptor for adoptive T cell therapy |
| title_full | Preclinical safety testing of an affinity-optimised MAGE-A10 T cell receptor for adoptive T cell therapy |
| title_fullStr | Preclinical safety testing of an affinity-optimised MAGE-A10 T cell receptor for adoptive T cell therapy |
| title_full_unstemmed | Preclinical safety testing of an affinity-optimised MAGE-A10 T cell receptor for adoptive T cell therapy |
| title_short | Preclinical safety testing of an affinity-optimised MAGE-A10 T cell receptor for adoptive T cell therapy |
| title_sort | preclinical safety testing of an affinity-optimised mage-a10 t cell receptor for adoptive t cell therapy |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646050/ http://dx.doi.org/10.1186/2051-1426-3-S2-P14 |
| work_keys_str_mv | AT gerryandrew preclinicalsafetytestingofanaffinityoptimisedmagea10tcellreceptorforadoptivetcelltherapy AT sandersonjoseph preclinicalsafetytestingofanaffinityoptimisedmagea10tcellreceptorforadoptivetcelltherapy AT sainimanoj preclinicalsafetytestingofanaffinityoptimisedmagea10tcellreceptorforadoptivetcelltherapy AT tavanobarbara preclinicalsafetytestingofanaffinityoptimisedmagea10tcellreceptorforadoptivetcelltherapy AT doctaroslin preclinicalsafetytestingofanaffinityoptimisedmagea10tcellreceptorforadoptivetcelltherapy AT pumphreynicholas preclinicalsafetytestingofanaffinityoptimisedmagea10tcellreceptorforadoptivetcelltherapy AT marotomiguel preclinicalsafetytestingofanaffinityoptimisedmagea10tcellreceptorforadoptivetcelltherapy AT borderellen preclinicalsafetytestingofanaffinityoptimisedmagea10tcellreceptorforadoptivetcelltherapy AT bennettalan preclinicalsafetytestingofanaffinityoptimisedmagea10tcellreceptorforadoptivetcelltherapy AT binderschollgwendolyn preclinicalsafetytestingofanaffinityoptimisedmagea10tcellreceptorforadoptivetcelltherapy AT holdichtom preclinicalsafetytestingofanaffinityoptimisedmagea10tcellreceptorforadoptivetcelltherapy AT panditelini preclinicalsafetytestingofanaffinityoptimisedmagea10tcellreceptorforadoptivetcelltherapy AT amadorafael preclinicalsafetytestingofanaffinityoptimisedmagea10tcellreceptorforadoptivetcelltherapy AT jakobsenbent preclinicalsafetytestingofanaffinityoptimisedmagea10tcellreceptorforadoptivetcelltherapy |